- Home
- TNGX vs VMO Comparison
TNGX vs VMO Comparison
Compare TNGX & VMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- VMO
- Stock Information
- Founded
- TNGX 2014
- VMO 1992
- Country
- TNGX United States
- VMO United States
- Employees
- TNGX N/A
- VMO N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- VMO Trusts Except Educational Religious and Charitable
- Sector
- TNGX Health Care
- VMO Finance
- Exchange
- TNGX Nasdaq
- VMO Nasdaq
- Market Cap
- TNGX 723.2M
- VMO 608.3M
- IPO Year
- TNGX N/A
- VMO N/A
- Fundamental
- Price
- TNGX $6.90
- VMO $9.18
- Analyst Decision
- TNGX Strong Buy
- VMO
- Analyst Count
- TNGX 6
- VMO 0
- Target Price
- TNGX $10.00
- VMO N/A
- AVG Volume (30 Days)
- TNGX 1.9M
- VMO 254.7K
- Earning Date
- TNGX 08-05-2025
- VMO 01-01-0001
- Dividend Yield
- TNGX N/A
- VMO 4.39%
- EPS Growth
- TNGX N/A
- VMO N/A
- EPS
- TNGX N/A
- VMO N/A
- Revenue
- TNGX $24,296,000.00
- VMO N/A
- Revenue This Year
- TNGX N/A
- VMO N/A
- Revenue Next Year
- TNGX N/A
- VMO N/A
- P/E Ratio
- TNGX N/A
- VMO N/A
- Revenue Growth
- TNGX N/A
- VMO N/A
- 52 Week Low
- TNGX $1.03
- VMO $7.86
- 52 Week High
- TNGX $12.02
- VMO $9.87
- Technical
- Relative Strength Index (RSI)
- TNGX 56.63
- VMO 51.98
- Support Level
- TNGX $6.60
- VMO $9.09
- Resistance Level
- TNGX $7.42
- VMO $9.31
- Average True Range (ATR)
- TNGX 0.47
- VMO 0.05
- MACD
- TNGX -0.04
- VMO -0.01
- Stochastic Oscillator
- TNGX 57.20
- VMO 40.91
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About VMO Invesco Municipal Opportunity Trust
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.